Tim Moore sold Colgate-Palmolive Company (NYSE: CL)
Tim Moore (R-NC), a U.S. Representative, has disclosed 1 trade in Colgate-Palmolive Company (CL) since 2025, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Tim Moore sold $1,001 - $15,000 of Colgate-Palmolive Company (NYSE: CL) on September 10, 2025. Since that trade, CL is up +14.52% against the S&P 500 up +12.79%, an outperformance of +1.73%.
Data updated
Tim Moore's CL trades vs the price
CL is up +14.52% since Tim Moore sold on September 10, 2025, versus +12.79% for the S&P 500.
Performance since this trade
All Tim Moore CL trades
Tim Moore & CL trading FAQ
Is it legal for Tim Moore to trade Colgate-Palmolive Company (CL) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Colgate-Palmolive Company (CL), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Tim Moore sell CL?
Tim Moore disclosed a sale of $1,001 - $15,000 of Colgate-Palmolive Company (CL) on September 10, 2025, according to public STOCK Act filings.
How has CL performed since Tim Moore's trade?
Since Tim Moore sold CL on September 10, 2025, the stock is up +14.52%, versus +12.79% for the S&P 500 over the same period, an outperformance of +1.73%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CL trades?
Quantellect tracks every disclosed congressional trade in Colgate-Palmolive Company (CL) on the Colgate-Palmolive Company congressional trading page, which aggregates filings across all members of Congress.
Tim Moore's CL tradesAll congressional filings for Colgate-Palmolive CompanyTim Moore's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.